We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Dantrium Intravenous 20 mg dantrolene sodium Powder for Solution for Injection
Section 19A approved medicine
(Approval lapsed) Dantrium Intravenous 20 mg dantrolene sodium Powder for Solution for Injection
Section 19A approval holder
Pfizer Australia Pty Ltd ABN 50 008 422 348
Phone
1800 675 229
Approved until
Status
Expired
Medicines in short supply/unavailable
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial - ARTG 14435
Indication(s)
For the treatment of malignant hyperthermia.